Glycoprotein IIb/IIIa antagonists and low-molecular weight heparin in acute coronary syndromes. [electronic resource]
Producer: 20011025Description: 235-52, vi p. digitalISSN:- 0733-8651
- Abciximab
- Angina, Unstable -- drug therapy
- Antibodies, Monoclonal -- adverse effects
- Coronary Artery Bypass
- Dalteparin -- therapeutic use
- Enoxaparin -- therapeutic use
- Eptifibatide
- Fibrinolytic Agents -- therapeutic use
- Hemorrhage -- chemically induced
- Heparin, Low-Molecular-Weight -- adverse effects
- Humans
- Immunoglobulin Fab Fragments -- adverse effects
- Myocardial Infarction -- drug therapy
- Nadroparin -- therapeutic use
- Peptides -- adverse effects
- Platelet Aggregation Inhibitors -- therapeutic use
- Platelet Glycoprotein GPIIb-IIIa Complex -- adverse effects
- Thrombocytopenia -- chemically induced
- Thrombosis -- chemically induced
- Tirofiban
- Transaminases -- blood
- Tyrosine -- adverse effects
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.